Machine learning and image-based profiling in drug discovery

Current Opinion in Systems Biology

Volumn 10, Issue , 2018, Pages 43-52

  Scheeder, Christian ^a   Heigwer, Florian ^a   Boutros, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Drug discovery; High content analysis; High throughput screening; Image analysis; Imaging; Machine learning

Indexed keywords

ETOPOSIDE;

ARTIFICIAL NEURAL NETWORK; CHEMICAL GENETICS; CONTENT ANALYSIS; DEEP NEURAL NETWORK; DRUG DEVELOPMENT; HIGH THROUGHPUT SCREENING; HUMAN; IMAGE ANALYSIS; IMAGE SEGMENTATION; IMAGING; MACHINE LEARNING; MICROSCOPY; NONHUMAN; REVIEW;

EID: 85048541417     PISSN: None     EISSN: 24523100     Source Type: Journal    
DOI: 10.1016/j.coisb.2018.05.004     Document Type: Review

References (87)

1. Nüsslein-Volhard, C., Wieschaus, E., Mutations affecting segment number and polarity in Drosophila. Nature 287 (1980), 795–801.
2. Sepp, K.J., Hong, P., Lizarraga, S.B., Liu, J.S., Mejia, L.A., Walsh, C.A., Perrimon, N., Identification of neural outgrowth genes using genome-wide RNAi. PLoS Genet, 4, 2008, e1000111.
3. Kiger, A.A., Baum, B., Jones, S., Jones, M.R., Coulson, A., Echeverri, C., Perrimon, N., A functional genomic analysis of cell morphology using RNA interference. J Biol, 2, 2003, 27.
4. Kamath, R.S., Ahringer, J., Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30 (2003), 313–321.
5. Boutros, M., Heigwer, F., Laufer, C., Microscopy-based high-content screening. Cell 163 (2015), 1314–1325.
6. Mattiazzi Usaj, M., Styles, E.B., Verster, A.J., Friesen, H., Boone, C., Andrews, B.J., High-content screening for quantitative cell biology. Trends Cell Biol 26 (2016), 598–611.
7. Pegoraro, G., Misteli, T., High-throughput imaging for the discovery of cellular mechanisms of disease. Trends Genet 33 (2017), 604–615.
8. Peters, J.M., Colavin, A., Shi, H., Czarny, T.L., Larson, M.H., Wong, S., Hawkins, J.S., Lu, C.H.S., Koo, B.M., Marta, E., et al. A comprehensive, CRISPR-based functional analysis of essential genes in bacteria. Cell 165 (2016), 1493–1506.
9. Kraus, O.Z., Grys, B.T., Ba, J., Chong, Y., Frey, B.J., Boone, C., Andrews, B.J., Automated analysis of high-content microscopy data with deep learning. Mol Syst Biol, 13, 2017, 924 A study that used deep learning to classify images of yeast cells according to the subcellular localization of fluorescently labeled proteins. This enabled an automated analysis of large-scale image data sets and further explored transfer learning as a framework to facilitate the adaption of deep learning to diverse biological data sets.
10. Neumann, B., Held, M., Liebel, U., Erfle, H., Rogers, P., Pepperkok, R., Ellenberg, J., High-throughput RNAi screening by time-lapse imaging of live human cells. Nat Methods 3 (2006), 385–390.
11. Huisken, J., Swoger, J., Del Bene, F., Wittbrodt, J., Stelzer, E.H.K., Optical sectioning deep inside live embryos by selective plane illumination microscopy. Science 305 (2004), 1007–1009.
12. Le, X., Pugach, E.K., Hettmer, S., Storer, N.Y., Liu, J., Wills, A.A., DiBiase, A., Chen, E.Y., Ignatius, M.S., Poss, K.D., et al. A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma development. Development 140 (2013), 2354–2364.
13. Bickle, M., The beautiful cell: high-content screening in drug discovery. Anal Bioanal Chem 398 (2010), 219–226.
14. Swinney, D.C., Anthony, J., How were new medicines discovered?. Nat Rev Drug Discov 10 (2011), 507–519.
15. Caicedo, J.C., Singh, S., Carpenter, A.E., Applications in image-based profiling of perturbations. Curr Opin Biotechnol 39 (2016), 134–142 This reference provides a concise review on the various applications of image-based profiling including drug discovery applications.
16. Fuchs, F., Pau, G., Kranz, D., Sklyar, O., Budjan, C., Steinbrink, S., Horn, T., Pedal, A., Huber, W., Boutros, M., Clustering phenotype populations by genome-wide RNAi and multiparametric imaging. Mol Syst Biol, 6, 2010, 370.
17. Zanella, F., Lorens, J.B., Link, W., High content screening: seeing is believing. Trends Biotechnol 28 (2010), 237–245.
18. Moffat, J.G., Vincent, F., Lee, J.A., Eder, J., Prunotto, M., Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat Rev Drug Discov 16 (2017), 531–543.
19. Lamb, J., Crawford, E.D., Peck, D., Modell, J.W., Blat, I.C., Wrobel, M.J., Lerner, J., Brunet, J.P., Subramanian, A., Ross, K.N., et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science (80-) 313 (2006), 1929–1935.
20. Schirle, M., Jenkins, J.L., Identifying compound efficacy targets in phenotypic drug discovery. Drug Discov Today 21 (2016), 82–89.
21. Schenone, M., Dančík, V., Wagner, B.K., Clemons, P.A., Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol 9 (2013), 232–240.
22. Singh, S., Carpenter, A.E., Genovesio, A., Increasing the Content of High-Content Screening. J Biomol Screen 19 (2014), 640–650.
23. Bray, M.-A., Singh, S., Han, H., Davis, C.T., Borgeson, B., Hartland, C., Kost-Alimova, M., Gustafsdottir, S.M., Gibson, C.C., Carpenter, A.E., Cell painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nat Protoc 11 (2016), 1757–1774 A methods paper providing comprehensive experimental guidelines for the CellPainting assay, an image-based profiling assay established by the Carpenter lab.
24. Fischer, B., Sandmann, T., Horn, T., Billmann, M., Chaudhary, V., Huber, W., Boutros, M., A map of directional genetic interactions in a metazoan cell. Elife, 4, 2015.
25. Breinig, M., Klein, F.A., Huber, W., Boutros, M., A chemical-genetic interaction map of small molecules using high-throughput imaging in cancer cells. Mol Syst Biol, 11, 2015, 846 A library of 1280 pharmacologically active small molecules was profiled in a panel of 12 isogenic human cancer cell lines to derive a multiparametric chemical-genetic interaction map to predict small molecule off-targets and to hypothesize drug repurposing possibilities. The imaging data can be browsed at http://dedomena.embl.de/PGPC/.
26. Bray, M.-A., Gustafsdottir, S.M., Rohban, M.H., Singh, S., Ljosa, V., Sokolnicki, K.L., Bittker, J.A., Bodycombe, N.E., Dančík, V., Hasaka, T.P., et al. A dataset of images and morphological profiles of 30 000 small-molecule treatments using the cell painting assay. Gigascience 6 (2017), 1–5.
27. Perlman, Z.E., Slack, M.D., Feng, Y., Mitchison, T.J., Wu, L.F., Altschuler, S.J., Multidimensional drug profiling by automated microscopy. Science 306 (2004), 1194–1198 This reference reports the first large-scale small molecule profiling study in human cells to connect drug mechanisms of action with image-based profiling.
28. Young, D.W., Bender, A., Hoyt, J., McWhinnie, E., Chirn, G.-W., Tao, C.Y., Tallarico, J.A., Labow, M., Jenkins, J.L., Mitchison, T.J., et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol 4 (2008), 59–68 The first that showed that similarity between phenotypic profiles can be correlated with chemical structure similarity. In some cases, small changes in chemical structure resulted in drastic phenotypic changes.
29. Gustafsdottir, S.M., Ljosa, V., Sokolnicki, K.L., Wilson, J.A., Walpita, D., Kemp, M.M., Seiler, K.P., Carrel, H.A., Golu, T.R., et al. Multiplex cytological profiling assay to measure diverse cellular states. PLoS One, 8, 2013.
30. Reisen, F., Sauty de Chalon, A., Pfeifer, M., Zhang, X., Gabriel, D., Selzer, P., Linking phenotypes and modes of action through high-content screen fingerprints. Assay Drug Dev Technol 13 (2015), 415–427.
31. Cacace, E., Kritikos, G., Typas, A., Chemical genetics in drug discovery. Curr Opin Syst Biol 4 (2017), 35–42.
32. Gibson, C.C., Zhu, W., Davis, C.T., Bowman-Kirigin, J.A., Chan, A.C., Ling, J., Walker, A.E., Goitre, L., Monache, S.D., Retta, S.F., et al. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 131 (2015), 289–299.
33. Schulze, C.J., Bray, W.M., Woerhmann, M.H., Stuart, J., Lokey, R.S., Linington, R.G., “Function-First” lead discovery: mode of action profiling of natural product libraries using image-based screening. Chem Biol 20 (2013), 285–295.
34. Wawer, M.J., Li, K., Gustafsdottir, S.M., Ljosa, V., Bodycombe, N.E., Marton, M.A., Sokolnicki, K.L., Bray, M.-A., Kemp, M.M., Winchester, E., et al. Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling. Proc Natl Acad Sci USA 111 (2014), 10911–10916.
35. Grimm, F.A., Iwata, Y., Sirenko, O., Bittner, M., Rusyn, I., High-content assay multiplexing for toxicity screening in induced pluripotent stem cell-derived cardiomyocytes and hepatocytes. Assay Drug Dev Technol 13 (2015), 529–546.
36. Sirenko, O., Hancock, M.K., Hesley, J., Hong, D., Cohen, A., Gentry, J., Carlson, C.B., Mann, D.A., Phenotypic characterization of toxic compound effects on liver spheroids derived from iPSC using confocal imaging and three-dimensional image analysis. Assay Drug Dev Technol 14 (2016), 381–394.
37. Woehrmann, M.H., Bray, W.M., Durbin, J.K., Nisam, S.C., Michael, A.K., Glassey, E., Stuart, J.M., Lokey, R.S., Large-scale cytological profiling for functional analysis of bioactive compounds. Mol Biosyst, 9, 2013, 2604.
38. Ochoa, J.L., Bray, W.M., Lokey, R.S., Linington, R.G., Phenotype-guided natural products discovery using cytological profiling. J Nat Prod 78 (2015), 2242–2248.
39. Kaufmann, M., Schuffenhauer, A., Fruh, I., Klein, J., Thiemeyer, A., Rigo, P., Gomez-Mancilla, B., Heidinger-Millot, V., Bouwmeester, T., Schopfer, U., et al. High-throughput screening using iPSC-derived neuronal progenitors to identify compounds counteracting epigenetic gene silencing in fragile X syndrome. J Biomol Screen 20 (2015), 1101–1111 By combining image-based assays with iPSC and 3-D cell culture systems those two references demonstrate the potential of image-based small molecule profiling to be applied in disease relevant model systems.
40. Booij, T.H., Bange, H., Leonhard, W.N., Yan, K., Fokkelman, M., Kunnen, S.J., Dauwerse, J.G., Qin, Y., van de Water, B., van Westen, G.J.P., et al. High-throughput phenotypic screening of kinase inhibitors to identify drug targets for polycystic kidney disease. SLAS Discov Adv life Sci RD 22 (2017), 974–984.
41. Oppermann, S., Ylanko, J., Shi, Y., Hariharan, S., Oakes, C.C., Brauer, P.M., Zúñiga-Pflücker, J.C., Leber, B., Spaner, D.E., Andrews, D.W., High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells. Blood 128 (2016), 934–947.
42. Giaever, G., Shoemaker, D.D., Jones, T.W., Liang, H., Winzeler, E.A., Astromoff, A., Davis, R.W., Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat Genet 21 (1999), 278–283.
43. Parsons, A.B., Lopez, A., Givoni, I.E., Williams, D.E., Gray, C.A., Porter, J., Chua, G., Sopko, R., Brost, R.L., Ho, C.H., et al. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126 (2006), 611–625.
44. Hillenmeyer, M.E., Fung, E., Wildenhain, J., Pierce, S.E., Hoon, S., Lee, W., Proctor, M., St. Onge, R.P., Tyers, M., Koller, D., et al. The chemical genomic portrait of yeast: Uncovering a phenotype for all genes. Science (80-) 320 (2008), 362–365.
45. Nichols, R.J., Sen, S., Choo, Y.J., Beltrao, P., Zietek, M., Chaba, R., Lee, S., Kazmierczak, K.M., Lee, K.J., Wong, A., et al. Phenotypic landscape of a bacterial cell. Cell 144 (2011), 143–156.
46. Lee, A.Y., St. Onge, R.P., Proctor, M.J., Wallace, I.M., Nile, A.H., Spagnuolo, P.A., Jitkova, Y., Gronda, M., Wu, Y., Kim, M.K., et al. Mapping the cellular response to small molecules using chemogenomic fitness signatures. Science (80-), 344, 2014.
47. Nijman, S.M.B., Functional genomics to uncover drug mechanism of action. Nat Chem Biol 11 (2015), 942–948.
48. Piotrowski, J.S., Li, S.C., Deshpande, R., Simpkins, S.W., Nelson, J., Yashiroda, Y., Barber, J.M., Safizadeh, H., Wilson, E., Okada, H., et al. Functional annotation of chemical libraries across diverse biological processes. Nat Chem Biol 13 (2017), 982–993 A large-scale chemical-genetic study in yeast that used an algorithm (COMPRESS-GI) to predict a diagnostic set of gene-deletion mutant strains based on genome-wide genetic interaction data. This provides a scalable-approach to functionally annotate large chemical libraries which might also be applicable to chemical-genetic studies in human cells.
49. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S., Wilson, C.J., Lehár, J., Kryukov, G.V., Sonkin, D., et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483 (2012), 603–607.
50. Iorio, F., Knijnenburg, T.A., Vis, D.J., Bignell, G.R., Menden, M.P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. A landscape of pharmacogenomic interactions in cancer. Cell 166 (2016), 740–754.
51. Seashore-Ludlow, B., Rees, M.G., Cheah, J.H., Coko, M., Price, E.V., Coletti, M.E., Jones, V., Bodycombe, N.E., Soule, C.K., Gould, J., et al. Harnessing connectivity in a large-scale small-molecule sensitivity dataset. Cancer Discov 5 (2015), 1210–1223.
52. Gilbert, D.F., Erdmann, G., Zhang, X., Fritzsche, A., Demir, K., Jaedicke, A., Muehlenberg, K., Wanker, E.E., Boutros, M., A novel multiplex cell viability assay for high-throughput RNAi screening. PLoS One, 6, 2011, e28338.
53. Moffat, J.G., Rudolph, J., Bailey, D., Phenotypic screening in cancer drug discovery — past, present and future. Nat Rev Drug Discov 13 (2014), 588–602.
54. Caie, P.D., Walls, R.E., Ingleston-Orme, A., Daya, S., Houslay, T., Eagle, R., Roberts, M.E., Carragher, N.O., High-content phenotypic profiling of drug response signatures across distinct cancer cells. Mol Cancer Ther 9 (2010), 1913–1926.
55. Warchal, S.J., Dawson, J.C., Carragher, N.O., Development of the theta comparative cell scoring method to quantify diverse phenotypic responses between distinct cell types. Assay Drug Dev Technol 14 (2016), 395–406.
56. Horvath, P., Wild, T., Kutay, U., Csucs, G., Machine learning improves the precision and robustness of high-content screens. J Biomol Screen 16 (2011), 1059–1067.
57. Grys, B.T., Lo, D.S., Sahin, N., Kraus, O.Z., Morris, Q., Boone, C., Andrews, B.J., Machine learning and computer vision approaches for phenotypic profiling. J Cell Biol 216 (2017), 65–71.
58. Sommer, C., Gerlich, D.W., Machine learning in cell biology – teaching computers to recognize phenotypes. J Cell Sci 126 (2013), 5529–5539.
59. Caicedo, J.C., Cooper, S., Heigwer, F., Warchal, S., Qiu, P., Molnar, C., Vasilevich, A.S., Barry, J.D., Bansal, H.S., Kraus, O., et al. Data-analysis strategies for image-based cell profiling. Nat Methods 14 (2017), 849–863 A community paper that was published following a Hackathon at the Broad Institute in 2016 with contributions from 20 laboratories assembled best practice guidelines for the analysis of image-based profiling data sets.
60. Ljosa, V., Caie, P.D., ter Horst, R., Sokolnicki, K.L., Jenkins, E.L., Daya, S., Roberts, M.E., Jones, T.R., Singh, S., Genovesio, A., et al. Comparison of methods for image-based profiling of cellular morphological responses to small-molecule treatment. J Biomol Screen 18 (2013), 1321–1329 In this study various computational methods to derive morphological profiles were benchmarked by classifying small molecules by their mechanism of action.
61. Reisen, F., Zhang, X., Gabriel, D., Selzer, P., Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery. J Biomol Screen 18 (2013), 1284–1297.
62. Eisen, M.B., Spellman, P.T., Brown, P.O., Botstein, D., Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95 (1998), 14863–14868.
63. Schuldiner, M., Collins, S.R., Thompson, N.J., Denic, V., Bhamidipati, A., Punna, T., Ihmels, J., Andrews, B., Boone, C., Greenblatt, J.F., et al. Exploration of the Function and organization of the yeast early secretory pathway through an epistatic miniarray profile. Cell 123 (2005), 507–519.
64. de Groot, R., Lüthi, J., Lindsay, H., Holtackers, R., Pelkmans, L., Large-scale image-based profiling of single-cell phenotypes in arrayed CRISPR-Cas9 gene perturbation screens. Mol Syst Biol, 14, 2018, e8064.
65. Bakal, C., Aach, J., Church, G., Perrimon, N., Quantitative morphological signatures define local signaling networks regulating cell morphology. Science (80-) 316 (2007), 1753–1756.
66. Sutherland, J.J., Low, J., Blosser, W., Dowless, M., Engler, T.A., Stancato, L.F., A robust high-content imaging approach for probing the mechanism of action and phenotypic outcomes of cell-cycle modulators. Mol Cancer Ther 10 (2011), 242–254.
67. Brandl, M.B., Pasquier, E., Li, F., Beck, D., Zhang, S., Zhao, H., Kavallaris, M., Wong, S.T.C., Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer. Mol Oncol 8 (2014), 1548–1560.
68. Booij, T.H., Klop, M.J.D., Yan, K., Szántai-Kis, C., Szokol, B., Orfi, L., van de Water, B., Keri, G., Price, L.S., Development of a 3D tissue culture–based high-content screening platform that uses phenotypic profiling to discrimainate selective inhibitors of receptor tyrosine kinases. J Biomol Screen 21 (2016), 912–922.
69. Loo, L.H., Wu, L.F., Altschuler, S.J., Image-based multivariate profiling of drug responses from single cells. Nat Methods 4 (2007), 445–453.
70. Kandaswamy, C., Silva, L.M., Alexandre, L.A., Santos, J.M., High-content analysis of breast cancer using single-cell deep transfer learning. J Biomol Screen 21 (2016), 252–259.
71. Kraus, O.Z., Ba, J.L., Frey, B.J., Classifying and segmenting microscopy images with deep multiple instance learning. Bioinformatics 32 (2016), i52–i59.
72. Dürr, O., Sick, B., Single-cell phenotype classification using deep convolutional neural networks. J Biomol Screen 21 (2016), 998–1003.
73. Pawlowski, N., Caicedo, J.C., Singh, S., Carpenter, A.E., Storkey, A., Automating morphological profiling with generic deep convolutional networks. bioRxiv, 2016, 10.1101/085118.
74. Godinez, W.J., Hossain, I., Lazic, S.E., Davies, J.W., Zhang, X., A multi-scale convolutional neural network for phenotyping high-content cellular images. Bioinformatics 33 (2017), 2010–2019.
75. Ando, D.M., McLean, C., Berndl, M., Improving phenotypic measurements in high-content imaging screens. bioRxiv, 2017, 10.1101/161422.
76. Sommer, C., Hoefler, R., Samwer, M., Gerlich, D.W., A deep learning and novelty detection framework for rapid phenotyping in high-content screening. Mol Biol Cell 28 (2017), 3428–3436.
77. Ounkomol, C., Fernandes, D.A., Seshamani, S., Maleckar, M.M., Collman, F., Johnson, G.R., Three dimensional cross-modal image inference: label-free methods for subcellular structure prediction. bioRxiv, 2017, 10.1101/216606.
78. O'Duibhir, E., Paris, J., Lawson, H., Sepulveda, C., Shenton, D.D., Carragher, N.O., Kranc, K.R., Machine learning enables live label-free phenotypic screening in three dimensions. Assay Drug Dev Technol 16 (2018), 51–63.
79. Simm, J., Klambauer, G., Arany, A., Steijaert, M., Wegner, J.K., Gustin, E., Chupakhin, V., Chong, Y.T., Vialard, J., Buijnsters, P., et al. Repurposing high-throughput image assays enables biological activity prediction for drug discovery. Cell Chem Biol, 0, 2018.
80. Costello, J.C., Heiser, L.M., Georgii, E., Gönen, M., Menden, M.P., Wang, N.J., Bansal, M., Ammad-Ud-Din, M., Hintsanen, P., Khan, S.A., et al. A community effort to assess and improve drug sensitivity prediction algorithms. Nat Biotechnol 32 (2014), 1202–1212.
81. Pau, G., Fuchs, F., Sklyar, O., Boutros, M., Huber, W., EBImage-an R package for image processing with applications to cellular phenotypes. Bioinformatics 26 (2010), 979–981.
82. Carpenter, A.E., Jones, T.R., Lamprecht, M.R., Clarke, C., Kang, I.H., Friman, O., Guertin, D.A., Chang, J.H., Lindquist, R.A., Moffat, J., et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol, 7, 2006, R100.
83. Jones, T.R., Carpenter, A., Golland, P., Voronoi-based segmentation of cells on image manifolds. 2005, Springer, Berlin, Heidelberg, 535–543.
84. Robinson, S., Guyon, L., Nevalainen, J., Toriseva, M., Åkerfelt, M., Nees, M., Segmentation of image data from complex organotypic 3D models of cancer tissues with markov random fields. PLoS One, 10, 2015, e0143798.
85. Uhlmann, V., Singh, S., Carpenter, A.E., CP-CHARM: segmentation-free image classification made accessible. BMC Bioinformatics, 17, 2016.
86. Rajaram, S., Pavie, B., Wu, L.F., Altschuler, S.J., PhenoRipper: software for rapidly profiling microscopy images. Nat Methods 9 (2012), 635–637.
87. Angermueller, C., Pärnamaa, T., Parts, L., Stegle, O., Deep learning for computational biology. Mol Syst Biol, 12, 2016, 878.